Antonio
Gómez Caamaño
Instituto Valenciano de Oncologia
Valencia, EspañaPublicacións en colaboración con investigadores/as de Instituto Valenciano de Oncologia (12)
2021
-
Management of localized muscle-invasive bladder cancer from a multidisciplinary perspective: Current position of the Spanish oncology genitourinary (Sogug)working group
Current Oncology, Vol. 28, Núm. 6, pp. 5084-5100
-
Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM
Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1281-1291
2019
-
Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database
Clinical and Translational Oncology, Vol. 21, Núm. 7, pp. 900-909
-
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051
2018
-
Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database
Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 193-200
-
Advanced imaging techniques in evaluation of colorectal cancer
Radiographics, Vol. 38, Núm. 3, pp. 740-765
2016
-
GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases
Annals of Oncology, Vol. 27, pp. vi383
-
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort
Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 1026-1033
2015
-
Nomogramme für die Prognose eines biochemischen Rezidivs beim Prostatakarzinom nach Strahlentherapie und Androgendeprivationstherapie
Strahlentherapie und Onkologie, Vol. 191, Núm. 10, pp. 792-800
2014
-
Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer
Clinical and Translational Oncology, Vol. 16, Núm. 5, pp. 447-454
2013
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572
2010
-
Spanish radiobiological pattern of care in lung cancer: A GOECP/SEOR study
Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 292-298